| Literature DB >> 23001182 |
Julia Skokowa1, Maxim Klimiankou, Olga Klimenkova, Dan Lan, Kshama Gupta, Kais Hussein, Esteban Carrizosa, Inna Kusnetsova, Zhixiong Li, Claudio Sustmann, Arnold Ganser, Cornelia Zeidler, Hans-Heinrich Kreipe, Janis Burkhardt, Rudolf Grosschedl, Karl Welte.
Abstract
We found that hematopoietic cell-specific Lyn substrate 1 (HCLS1 or HS1) is highly expressed in human myeloid cells and that stimulation with granulocyte colony-stimulating factor (G-CSF) leads to HCLS1 phosphorylation. HCLS1 binds the transcription factor lymphoid-enhancer binding factor 1 (LEF-1), transporting LEF-1 into the nucleus upon G-CSF stimulation and inducing LEF-1 autoregulation. In patients with severe congenital neutropenia, inherited mutations in the gene encoding HCLS1-associated protein X-1 (HAX1) lead to profound defects in G-CSF-triggered phosphorylation of HCLS1 and subsequently to reduced autoregulation and expression of LEF-1. Consistent with these results, HCLS1-deficient mice are neutropenic. In bone marrow biopsies of the majority of tested patients with acute myeloid leukemia, HCLS1 protein expression is substantially elevated, associated with high levels of G-CSF synthesis and, in some individuals, a four-residue insertion in a proline-rich region of HCLS1 protein known to accelerate intracellular signaling. These data demonstrate the importance of HCLS1 in myelopoiesis in vitro and in vivo.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23001182 PMCID: PMC3941918 DOI: 10.1038/nm.2958
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440